A multi-centre, randomised, double-blind, placebo-controlled phase iii clinical trial evaluating the impact of bcg re-vaccination on the incidence and severity of sars-cov-2 infections among symptomatic healthcare professionals during the covid-19 pandemic in poland—evaluation of antibody concentrations

HIGHLIGHTS

  • who: Paweu0142 Zapolnik and colleagues from the College of Medical Sciences, University of Rzeszu00f3w, Rzeszu00f3w, Poland have published the paper: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Polandu2014Evaluation of Antibody Concentrations, in the Journal: Vaccines 2023, 11, 75. of 12/04/2022
  • what: The aim of the research is to evaluate the effect of revaccination with the BCG-10 vaccine (Biomed Lublin SA . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?